In our study, depletion of CD8+ T cells or neutralisation of IFNγ abrogated the anti‐tumor efficacy of anti‐RANKL/PD‐1 BsAb suggesting major roles for adaptive immune cells in the response. The gene discussed is TNFSF11; the disease is neoplasm.